NTRK2 and lung cancer: TrkBT695I and TrkBD751N in colon cancer-derived mutants showed less activity than wild-type TrkB, and the function of TrkBL138F in lung cancer and TrkBP507L in breast cancer was indistinguishable from wild-type [70].